Chloroform

CHEMBL44618 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
119.4 g/mol
LogP
2.3
Phase
4

A halogenated hydrocarbon historically used as a general anesthetic and sedative that produces CNS depression through mechanisms affecting chloride channels and other neuronal targets. Its use in medicine has been entirely abandoned due to its narrow therapeutic index, hepatotoxicity, nephrotoxicity, and potential carcinogenicity. It now has only research and industrial chemical applications.

分子量

119.3700 g/mol

LogP

2.30

TPSA

0.00 Ų

Lipinski 五规则

符合

治疗领域

作用机制

Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

机制

Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

ClC(Cl)Cl

InChI

InChI=1S/CHCl3/c2-1(3)4/h1H

Molecular Formula

CHCl3

HBD / HBA

- / -

可旋转键数

0

重原子数

4

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

A halogenated hydrocarbon historically used as a general anesthetic and sedative that produces CNS depression through mechanisms affecting chloride channels and other neuronal targets. Its use in medicine has been entirely abandoned due to its narrow therapeutic index, hepatotoxicity, nephrotoxicity, and potential carcinogenicity. It now has only research and industrial chemical applications.

Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.

Yes, Chloroform is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL44618. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6212. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.